journal article·2006-03-15

Alkaline‐treated poly(ϵ‐caprolactone) films: Degradation in the presence or absence of fibroblasts

Juan Peña, Teresa Corrales, Isabel Izquierdo‐Barba, M. Concepción Serrano, M. Teresa Portolés, Raffaella Pagani, María Vallet‐Regí

Publisher page

Abstract

Abstract In the first stage, we observed the study of the degradation behavior of alkaline‐treated poly(ϵ‐caprolactone) (PCL) in two biologically‐related media: phosphate buffered saline (PBS) and Dulbecco's modified Eagle's medium (DMEM) for 18 months, finding a much accelerated degradation in the last one. As expected, the degradation in the presence of cells is much pronounced even considering that the study is limited to 6 months. The characterization of the degraded substrates by chemiluminescence (CL) allows to explain the modifications of the substrate and their relations with transitory oxidative stress phenomena described in the fibroblasts seeded onto the PCL membranes. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. 10.1201/978020390467110.1201/9780203904671 ↗
2. 10.1016/0142-9612(95)93577-Z10.1016/0142-9612(95)93577-Z ↗
3. 10.1016/S0142-9612(00)00101-010.1016/S0142-9612(00)00101-0 ↗
4. 10.1002/jbm.a.1049710.1002/jbm.a.10497 ↗
5. 10.1016/j.biomaterials.2004.03.00510.1016/j.biomaterials.2004.03.005 ↗
6. 10.1002/jbm.a.1010110.1002/jbm.a.10101 ↗
7. 10.1097/00000658-199807000-0000210.1097/00000658-199807000-00002 ↗
8. 10.1038/614610.1038/6146 ↗
9. 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J ↗
10. 10.1163/15685620432304690610.1163/156856204323046906 ↗
11. 10.1016/j.biomaterials.2004.07.00610.1016/j.biomaterials.2004.07.006 ↗
12. 10.1016/j.biomaterials.2003.11.02210.1016/j.biomaterials.2003.11.022 ↗
13. 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.0.CO;2-Z10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.0.CO;2-Z ↗
14. 10.1016/S0142-9612(03)00535-010.1016/S0142-9612(03)00535-0 ↗
15. 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-810.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8 ↗
16. 10.1016/S0142-9612(02)00247-810.1016/S0142-9612(02)00247-8 ↗
17. 10.1016/j.biomaterials.2003.08.03810.1016/j.biomaterials.2003.08.038 ↗
18. 10.1163/15685620376923156510.1163/156856203769231565 ↗
19. 10.1023/A:102205951126110.1023/A:1022059511261 ↗
20. 10.1002/jbm.a.2003710.1002/jbm.a.20037 ↗
21. 10.1016/j.biomaterials.2003.08.06410.1016/j.biomaterials.2003.08.064 ↗
22. 10.1002/app.1068010.1002/app.10680 ↗
23. 10.1016/S0142-9612(03)00471-X10.1016/S0142-9612(03)00471-X ↗
24. 10.1002/jbm.82029091010.1002/jbm.820290910 ↗
25. 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T ↗
26. 10.1002/jbm.82027121210.1002/jbm.820271212 ↗
27. 10.1002/mabi.20040021410.1002/mabi.200400214 ↗
28. 10.1016/j.biomaterials.2005.02.03910.1016/j.biomaterials.2005.02.039 ↗
29. 10.1016/0142-9612(93)90063-810.1016/0142-9612(93)90063-8 ↗
30. 10.1006/excr.2001.544710.1006/excr.2001.5447 ↗
31. 10.1161/01.CIR.0000028465.52694.9B10.1161/01.CIR.0000028465.52694.9B ↗
32. 10.1093/toxsci/51.1.8010.1093/toxsci/51.1.80 ↗
33. 10.1002/pola.1041910.1002/pola.10419 ↗
34. 10.1016/S1010-6030(03)00004-210.1016/S1010-6030(03)00004-2 ↗
35. George GA · 1981 · 173
36. Celina M · 1996 · 15910.1021/ba-1996-0249.ch011 ↗
37. 10.1016/S0141-3910(01)00224-510.1016/S0141-3910(01)00224-5 ↗
38. Corrales T · 2004
39. 10.1021/ja01048a00510.1021/ja01048a005 ↗
40. 10.1016/0141-3910(94)00134-T10.1016/0141-3910(94)00134-T ↗
41. 10.1016/0141-3910(95)00151-410.1016/0141-3910(95)00151-4 ↗
42. 10.1016/0032-3861(93)90690-C10.1016/0032-3861(93)90690-C ↗
43. Poly(ϵ‐caprolactone) films long term degradation in biologically related fluids
44. Crystallization behaviour of PCL in hybrid confined environment
45. 10.1163/15685620432304693310.1163/156856204323046933 ↗
46. 10.1002/pi.119910.1002/pi.1199 ↗
47. Barbucci R · 2002 · 84310.1007/b112196 ↗
48. 10.1016/0141-3910(93)90031-D10.1016/0141-3910(93)90031-D ↗
49. 10.1016/S0141-3910(01)00034-910.1016/S0141-3910(01)00034-9 ↗
50. 10.1002/(SICI)1097-4636(200001)49:1<25::AID-JBM4>3.0.CO;2-I10.1002/(SICI)1097-4636(200001)49:1<25::AID-JBM4>3.0.CO;2-I ↗
51. 10.1002/pol.1961.120501531210.1002/pol.1961.1205015312 ↗
52. 10.1016/0141-3910(96)00079-110.1016/0141-3910(96)00079-1 ↗